• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼠李糖乳杆菌补充剂对基于左氧氟沙星的抗幽门螺杆菌二线治疗的影响。

Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.

机构信息

Departement of Internal Medicine, Catholic University of Rome, 00168 Rome, Italy.

出版信息

Gastroenterol Res Pract. 2012;2012:740381. doi: 10.1155/2012/740381. Epub 2012 May 29.

DOI:10.1155/2012/740381
PMID:22690211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3368352/
Abstract

Introduction. Helicobacter pylori eradication therapy has the potential burden of antibiotic-associated gastrointestinal (GI) side effects. The occurrence of side effects is among the major drawbacks of such regimens. GI manifestations may be related to alterations in the intestinal microflora. Probiotics can prevent or reduce antibiotic-associated side effects and have an inhibitory effect on H. pylori. Methods. To define the efficacy of Lactobacillus reuteri supplementation in H. pylori eradication and in preventing GI-associated side effects during a second-line levofloxacin triple therapy. 90 H. pylori-positive patients receive for 7 days a second-line triple therapy with esomeprazole, levofloxacin, and amoxicillin with L. reuteri for 14 days (group 1) and without probiotic supplementation (group 2). Each subject received a validated questionnaire to record symptoms everyday for 4 weeks from the start of therapy. H. pylori status and side effects were assessed 6 weeks after treatment. Results. The eradication rate was significantly influenced by probiotic supplementation with L. reuteri (group 1: 36/45, 80%; group 2: 28/45 62%; P < 0.05). The incidence of nausea and diarrhoea in group 1 was significantly lower than that in group 2. Conclusion. In H. pylori-positive subjects L. reuteri supplementation increases the eradication rate while reducing the incidence of the most common side effects associated with antibiotic therapy in second-line treatment.

摘要

简介。幽门螺杆菌根除疗法可能会带来抗生素相关的胃肠道(GI)副作用负担。副作用的发生是此类方案的主要缺点之一。GI 表现可能与肠道菌群的改变有关。益生菌可预防或减少抗生素相关的副作用,并对幽门螺杆菌具有抑制作用。方法。为了确定补充罗伊氏乳杆菌在幽门螺杆菌根除和预防二线左氧氟沙星三联疗法中与 GI 相关副作用的疗效。90 例幽门螺杆菌阳性患者接受埃索美拉唑、左氧氟沙星和阿莫西林的二线三联疗法 7 天,并同时补充罗伊氏乳杆菌 14 天(第 1 组)或不补充益生菌(第 2 组)。每位受试者在治疗开始后 4 周内每天使用经过验证的问卷记录症状。治疗 6 周后评估幽门螺杆菌状态和副作用。结果。补充罗伊氏乳杆菌显著影响根除率(第 1 组:45 例中有 36 例,80%;第 2 组:45 例中有 28 例,62%;P<0.05)。第 1 组恶心和腹泻的发生率明显低于第 2 组。结论。在幽门螺杆菌阳性患者中,补充罗伊氏乳杆菌可提高根除率,同时降低二线治疗中抗生素治疗最常见副作用的发生率。

相似文献

1
Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.鼠李糖乳杆菌补充剂对基于左氧氟沙星的抗幽门螺杆菌二线治疗的影响。
Gastroenterol Res Pract. 2012;2012:740381. doi: 10.1155/2012/740381. Epub 2012 May 29.
2
compared with placebo as an adjuvant in eradication therapy: a meta-analysis of randomized controlled trials.与安慰剂作为根除治疗辅助剂的比较:随机对照试验的荟萃分析。
Therap Adv Gastroenterol. 2024 Jun 5;17:17562848241258021. doi: 10.1177/17562848241258021. eCollection 2024.
3
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.补充益生菌治疗幽门螺杆菌根除的疗效:一项随机对照试验的荟萃分析。
PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016.
4
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.基于左氧氟沙星的二线三联方案用于根除幽门螺杆菌
Dig Liver Dis. 2009 Jul;41(7):480-5. doi: 10.1016/j.dld.2008.09.013. Epub 2008 Oct 30.
5
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.不同益生菌制剂对幽门螺杆菌治疗相关副作用的影响:一项平行组、三盲、安慰剂对照研究。
Am J Gastroenterol. 2002 Nov;97(11):2744-9. doi: 10.1111/j.1572-0241.2002.07063.x.
6
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.基于左氧氟沙星的三联疗法用于幽门螺杆菌根除的一线治疗。
Am J Gastroenterol. 2006 Sep;101(9):1985-90. doi: 10.1111/j.1572-0241.2006.00716.x.
7
Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.补充益生菌的三联疗法根除儿童幽门螺杆菌的疗效和安全性:一项系统评价和网状Meta分析
Eur J Clin Pharmacol. 2017 Oct;73(10):1199-1208. doi: 10.1007/s00228-017-2291-6. Epub 2017 Jul 5.
8
A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.一项比较两种含左氧氟沙星的二线疗法根除幽门螺杆菌的随机对照试验。
Medicine (Baltimore). 2016 May;95(19):e3586. doi: 10.1097/MD.0000000000003586.
9
Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.四环素-左氧氟沙星与阿莫西林-左氧氟沙星四联疗法在幽门螺杆菌感染二线治疗中的比较。
Helicobacter. 2021 Oct;26(5):e12840. doi: 10.1111/hel.12840. Epub 2021 Aug 12.
10
Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.罗伊氏乳杆菌治疗消化不良患者幽门螺杆菌感染的双盲安慰剂对照随机临床试验。
Therap Adv Gastroenterol. 2014 Jan;7(1):4-13. doi: 10.1177/1756283X13503514.

引用本文的文献

1
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature.益生菌在消化不良治疗中的治疗作用:文献综述
Neurogastroenterol Motil. 2025 Oct;37(10):e70057. doi: 10.1111/nmo.70057. Epub 2025 May 7.
2
Inhibitory effects of Lactobacillus reuteri strain I300 against Helicobacter pylori adhesion, invasion, and inflammatory response in gastric epithelial cells in vitro.罗伊氏乳杆菌I300株对幽门螺杆菌在体外胃上皮细胞中黏附、侵袭及炎症反应的抑制作用
Folia Microbiol (Praha). 2025 Apr 17. doi: 10.1007/s12223-025-01263-7.
3
Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance.乳酸杆菌属对幽门螺杆菌的影响:抗生素耐药时代的一个有前景的前沿领域。
Probiotics Antimicrob Proteins. 2024 Nov 5. doi: 10.1007/s12602-024-10396-z.
4
Clinical Dilemmas for the Diagnosis and Treatment of Infection in Children: From Guideline to Practice.儿童感染诊断与治疗中的临床困境:从指南到实践
Pediatr Gastroenterol Hepatol Nutr. 2024 Sep;27(5):267-273. doi: 10.5223/pghn.2024.27.5.267. Epub 2024 Sep 9.
5
compared with placebo as an adjuvant in eradication therapy: a meta-analysis of randomized controlled trials.与安慰剂作为根除治疗辅助剂的比较:随机对照试验的荟萃分析。
Therap Adv Gastroenterol. 2024 Jun 5;17:17562848241258021. doi: 10.1177/17562848241258021. eCollection 2024.
6
Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis.不同益生菌补充剂对三联幽门螺杆菌根除效果的比较:网络荟萃分析。
Front Cell Infect Microbiol. 2023 May 15;13:1120789. doi: 10.3389/fcimb.2023.1120789. eCollection 2023.
7
Gastric microbiota: an emerging player in gastric cancer.胃微生物群:胃癌中一个新出现的因素
Front Microbiol. 2023 Apr 27;14:1130001. doi: 10.3389/fmicb.2023.1130001. eCollection 2023.
8
Probiotics for the Prevention of Antibiotic-Associated Diarrhea.益生菌预防抗生素相关性腹泻
Healthcare (Basel). 2022 Aug 2;10(8):1450. doi: 10.3390/healthcare10081450.
9
Effect of a Probiotic Mixture in Captive Cheetahs () with Gastrointestinal Symptoms-A Pilot Study.益生菌混合物对患有胃肠道症状的圈养猎豹的影响——一项初步研究
Animals (Basel). 2022 Feb 7;12(3):395. doi: 10.3390/ani12030395.
10
Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases.肠道与大脑:探究微生物群与大脑之间的生理和病理相互作用以获取脑部疾病的新治疗途径
Front Neurosci. 2021 Oct 12;15:753915. doi: 10.3389/fnins.2021.753915. eCollection 2021.

本文引用的文献

1
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.左氧氟沙星三联疗法与克拉霉素三联疗法序贯治疗幽门螺杆菌根除的随机试验。
Gut. 2010 Nov;59(11):1465-70. doi: 10.1136/gut.2010.215350.
2
Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.荟萃分析:含乳酸杆菌的四联疗法与标准三联一线疗法根除幽门螺杆菌的对比
Helicobacter. 2009 Oct;14(5):97-107. doi: 10.1111/j.1523-5378.2009.00716.x.
3
Health benefits of probiotics and prebiotics in women.益生菌和益生元对女性的健康益处。
Menopause Int. 2009 Mar;15(1):35-40. doi: 10.1258/mi.2009.009008.
4
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.基于左氧氟沙星的二线三联方案用于根除幽门螺杆菌
Dig Liver Dis. 2009 Jul;41(7):480-5. doi: 10.1016/j.dld.2008.09.013. Epub 2008 Oct 30.
5
Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study.罗伊氏乳杆菌ATCC 55730对人类幽门螺杆菌感染的抑制作用及其对根除治疗的影响:一项初步研究。
Helicobacter. 2008 Apr;13(2):127-34. doi: 10.1111/j.1523-5378.2008.00593.x.
6
Treatment of Helicobacter pylori.幽门螺杆菌的治疗。
Helicobacter. 2007 Oct;12 Suppl 1:31-7. doi: 10.1111/j.1523-5378.2007.00538.x.
7
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.益生菌和益生元在炎症性肠病中应用的证据:一项临床试验综述
Proc Nutr Soc. 2007 Aug;66(3):307-15. doi: 10.1017/S0029665107005563.
8
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2007 Apr 18(2):CD004827. doi: 10.1002/14651858.CD004827.pub2.
9
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.荟萃分析:补充益生菌对幽门螺杆菌根除治疗期间根除率和不良事件的影响
Aliment Pharmacol Ther. 2007 Jan 15;25(2):155-68. doi: 10.1111/j.1365-2036.2006.03179.x.
10
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.幽门螺杆菌感染管理的当前概念:马斯特里赫特III共识报告。
Gut. 2007 Jun;56(6):772-81. doi: 10.1136/gut.2006.101634. Epub 2006 Dec 14.